beta-D-Galp-(1->3)-D-GlcpN → D-Galactosamine

HRID 341729

반응식

HRID 341729 반응식
[O:1]([C@H:13]1[C@H:19]([OH:20])[C@@H:18]([CH2:21][OH:22])[O:17][CH:15]([OH:16])[C@@H:14]1[NH2:23])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O.[O:24]([C@H:36]1[C@@H:42]([OH:43])[C@@H:41]([CH2:44][OH:45])[O:40][CH:38]([OH:39])[C@@H:37]1[NH2:46])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O>>[OH:16][CH:15]1[O:17][C@H:18]([CH2:21][OH:22])[C@@H:19]([OH:20])[C@H:13]([OH:1])[C@H:14]1[NH2:23].[OH:39][CH:38]1[O:40][C@H:41]([CH2:44][OH:45])[C@H:42]([OH:43])[C@H:36]([OH:24])[C@H:37]1[NH2:46]

참가 물질

4

실험 절차

Example 3-Synthesis of Galβ1-3GlcNH2 βSEt and Galβ1-3GalNH2 βSEt. See example 1, similar conditions and enzyme may be used, but instead GlcNH2 βSEt, or GalNH2 βSEt to obtain the latter product, is used as the acceptor. Here, extraction is less favorable for isolation, and instead ion-exchanger as above may be used followed by e.g. precipitation or a second chromatographic step.

출처 및 근거

ORD 기록
ord-5ef8e7d94c794f6c9be4623ae826bc31
출처 데이터셋
uspto-grants-1999_01
특허 번호
US05856143

연결된 노트

불러오는 중…